Federal Register · Regulatory notice
Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules
A Notice notice explicitly mentions the company. Read the cited text for its role.
Follow NVS- Became public
- Sep 17, 2026
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 1:07 AM EST
Why this is connected
The source explicitly mentions NOVARTIS AG. A mention alone does not establish a financial benefit.
Source evidence
Read the source excerpt or record
---------------------------------------- 07/28/2026 ------------------------------------------------------------------------ 20260922.......................... S IonQ, Inc.; SkyWater Technology, Inc.; IonQ, Inc. 20261756.......................... G Enstructure Holdco LLC; BW Phoenix Co-Invest, L.P.; Enstructure Holdco LLC. 20261757.......................... G Platinum Equity Small Cap Fund II, L.P.; Grand Appliance, Inc.; Platinum Equity Small Cap Fund II, L.P. 20261761.......................... G Matthew Holt; Ensemble Health Partners Holdings, LLC; Matthew Holt. 20261765.......................... G LongRange Capital Fund I, L.P.; Yum! Brands, Inc.; LongRange Capital Fund I, L.P. 20261766.......................... G HP Prestige Aggregator, LP; Health Catalyst, Inc.; HP Prestige Aggregator, LP. 20261773.......................... G Walmart Inc.; Vibe SAS; Walmart Inc. 20261774.......................... G Relevate Parent Holdings, LP; Relevate Holdings, LP; Relevate Parent Holdings, LP. 20261783.......................... G Korn Ferry; OMERS Administration Corporation; Korn Ferry. 20261796.......................... G Schneider Electric SE; AiDash Inc.; Schneider Electric SE. 20261799.......................... G Neon Maple Parent Inc.; Payoneer Global Inc.; Neon Maple Parent Inc. 20261801.......................... G ARX Parent Holdings, LP; Flexpoint Fund IV-A, L.P.; ARX Parent Hol
Congressional trading in NVS
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 25, 2026$15K–$50K
Rep. Kevin Hern (R-OK-1)
$15K–$50K · Traded Aug 27, 2026 · disclosed Sep 25, 2026
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 31, 2026 · disclosed Jul 21, 2026 · filed 112 days later
Committee overlap: HELP - Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
$15K–$50K · Traded Mar 30, 2026 · disclosed Jul 21, 2026 · filed 113 days later
Committee overlap: HELP - Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 31, 2025 · disclosed Nov 21, 2025 · Spouse
- Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 21, 2025 · Spouse
- Nov 21, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Oct 30, 2025 · disclosed Nov 21, 2025 · Spouse
- Oct 22, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
Sold (partial) Novartis AG NVS
$1K–$15K · Traded Sep 25, 2025 · disclosed Oct 22, 2025 · Spouse
- Oct 22, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Sep 11, 2025 · disclosed Oct 22, 2025 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.